Both in Pharmaceuticals
Traws Pharma vs Xenetic Biosciences
Over the past year TRAW returned −87.8% and XBIO returned −29.5%; their daily moves had a correlation of 0.06.
TRAW −87.8% XBIO −29.5%Growth of $1, one year, split-adjusted
| Metric | TRAW | XBIO |
|---|---|---|
| Price | $0.2686 | $2.01 |
| Market cap | $4.1M | $4.7M |
| Today | −11.06% | −3.37% |
| 1 month | −48.3% | −5.2% |
| 6 months | −84.2% | −36.6% |
| Year to date | −76.2% | −7.4% |
| 1 year | −88.8% | −35.6% |
| Revenue growth (YoY) | −100.0% | +12.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −140.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.2× |
| Net cash | $5.0M | $6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 82.3% | 158.5% |
| Short % of float | 5.2% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).